During the past decade, Interni Ambulance conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Interni Ambulance" are "Coronary Heart Disease (CHD)" (1 trials) and "Severe Hypertriglyceridemia" (1 trials). Many other conditions were trialed in "Interni Ambulance" in a lesser frequency.

Most popular intervention types in "Interni Ambulance" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Evolocumab" (1 trials) and "Olezarsen" (1 trials). Other intervention names were less common.

The vast majority of trials in "Interni Ambulance" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Interni Ambulance". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Interni Ambulance, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Interni Ambulance, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".